Pharmacology of the pyrroloimidazole, SK&F 105809—II: Antiinflammatory activity and inhibition of mediator production in vivo
- 25 July 1991
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 42 (4) , 825-831
- https://doi.org/10.1016/0006-2952(91)90042-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Substance P, Cytokines, and ArthritisAnnals of the New York Academy of Sciences, 1990
- The role of eicosanoids in inflammationProgress in Lipid Research, 1986
- Phlogistic activity of leukotriene D4 in the mouseInflammation, 1986
- Leukotriene B 4 Produces Hyperalgesia That Is Dependent on Polymorphonuclear LeukocytesScience, 1984
- Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1983
- Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4British Journal of Pharmacology, 1983
- CHEMOTACTIC LIPOXYGENASE PRODUCTS IN PSORIASISThe Lancet, 1983
- LEUKOTRIENE B4, AN INFLAMMATORY MEDIATOR IN GOUTThe Lancet, 1982
- Leukotriene B4General Pharmacology: The Vascular System, 1981
- Species difference in increased vascular permeability by synthetic leukotriene C4 and D4Prostaglandins, 1981